Background: Postoperative atrial fibrillation (PoAF) remains a significant risk factor for increased morbidity and mortality after cardiac surgery. The ability to accurately identify patients at risk through clinical risk factors is limited. There is growing evidence that polygenic risk contributes significantly to PoAF and incorporating measures of genetic risk could enhance prediction. Methods: A retrospective cohort study of 1047 patients of White European ancestry who underwent either coronary artery bypass grafting or valve surgery at a tertiary academic center and were free from a history or persistent preoperative atrial fibrillation. The primary outcome was defined as PoAF based on postoperative ECG reports, medical record documentation, and changes in medication. The exposure was a polygenic risk score (PRS) comprising 2746 single-nucleotide polymorphisms previously associated with atrial fibrillation risk. The prediction of PoAF risk was assessed using measures of model discrimination, calibration, and net reclassification improvement. Results: A total of 259 patients (24.7%) developed PoAF. The PRS was significantly associated with a higher risk for PoAF (odds ratio, 1.63 per SD increase in PRS [95% CI, 1.41–1.90]). Addition of PRS to patient- and procedure-related predictors of PoAF significantly increased the C statistic from 0.742 to 0.782 (change in C statistic, 0.040 [95% CI, 0.021–0.060]) while maintaining good calibration. The addition of the PRS to patient- and procedure-related predictors of PoAF improved model fit (likelihood ratio test, P =2.8×10 −15 ) and significantly improved measures of reclassification (net reclassification improvement, 0.158 [95% CI, 0.066–0.274]). Conclusions: The PRS for PoAF was associated with improved discrimination, calibration, and risk reclassification compared with conventional clinical predictors suggesting that a PoAF PRS may enhance risk prediction of PoAF in patients undergoing coronary artery bypass grafting or valve surgery.
Smartphone applications related to coronavirus disease 2019 (COVID-19) continue to emerge and evolve, but despite a wide variety of different app functions, there has yet to be a comprehensive study of what the most prevalent publicly available apps provide, and there exists no standardized evaluation system for end users to determine the safety and efficacy of an app before they download it. Furthermore, limited oversight means that the rapidly growing space creates challenges for end users trying to find a relevant app. We adapted the M-Health Index and Navigation Database (MIND) from apps.digitalpsych.org that previously has been used to evaluate mental health applications to guide the assessment of COVID apps. Using this framework, we conducted a thorough analysis of the top-100 returned coronavirus apps on two separate dates a month apart to understand the clinical utility and features of COVID-19 apps and how these change in a short period of time. We ultimately identified a significant turnover rate, as well as privacy concerns around lack of privacy policies and disclosure of personal information. Our research offers insight into the current status of COVID-19 apps and provides a comprehensive and adaptable framework to help individuals assess the growing number of such digital tools in the wake of the pandemic.
Transglutaminases are pleiotropic enzymes that in mosquitoes participate in the formation of the mating plug and the wound-induced antimalarial response. Moreover, one transglutaminase, TGase3, negatively regulates the infection-induced aggregation of hemocytes on the heart. Given that TGase3 is an inhibitor of periostial hemocyte aggregation, we used RNAi-based gene silencing followed by intravital video imaging to scrutinize whether any of the three transglutaminases encoded in the genome of the mosquito, Anopheles gambiae, play a role in modulating the heart rate of uninfected and infected mosquitoes. Initially, we confirmed that an infection decreases the heart rate. Then, we uncovered that silencing TGase1 does not impact heart physiology, but silencing TGase2 results in a constant heart rate regardless of infection status, eliminating the infection-induced decrease in the heart rate. Finally, silencing TGase3 decreases the heart rate in uninfected mosquitoes but increases the heart rate in infected mosquitoes. We conclude that TGase2 and TGase3 modulate heart physiology and demonstrate that factors not classically associated with insect circulatory physiology are involved in the functional integration of the immune and circulatory systems of mosquitoes.